The recent, rapid developments in the scientific understanding of the structure and function of clostridial toxins have opened the door to therapeutic uses of and treatments against these potent neurotoxins. They have found applications in treating focal dystonias, spastic paralysis in children with cerebral palsey, pain relief, and as targeted drug delivery agents for the nervous system. . Many clinicians, however, are using preparations without awareness of available information that could improve and expand their use. This book integrates the most recent scientific and clinical information from top international authorities covering the structure, mechanisms of action with current and emerging applications of these toxins.
Inhaltsverzeichnis
Introduction and Historical Perspective. Three-Dimensional Protein Structures of Light Chains of Botulinum Neurotoxin Serotypes A, B, and E and Tetanus Neurotoxin. Mechanisms of Actions of Neurotoxins. Vaccines to Protect against Neurotoxins. Inhibitors of Clostridial Neurotoxin Proteinase Activities. Introduction to Clinical Use of Botulinum Neurotoxins. Expanding Clinical Uses of Botulinum Neurotoxins. Development of Therapeutics Based upon Clostridial Endopeptidase Activity. Use of Neurotoxins as Drug Delivery Systems. Conclusions and Future Perspectives: Botulinum Neurotoxins as Paradigms for Development of Microbial Effector-Derived Drugs. Index.